Tweets
What is new in PsA?
Dennis McGonagle's take at #EULAR2026
-a strong year for discovery in mechanisms of transition from PSO to PsA
-publication of the first single cell atlas Enthesis
-Better understanding of VTE mechanisms in JAKi in PsA
-clinical aspects of Axial involvement https://t.co/v9cfn1y4fH
Aurelie Najm @AurelieRheumo ( View Tweet )
2 weeks 4 days ago
Pts with AIIRD carry a high risk & burden of infection due to immune dysregulation, comorbids, GC/DMaRD use.
As a rheumatologist, do you vaccinate your patients?
#EULAR2026 @RheumNow
sheila @RHEUMarampa ( View Tweet )
2 weeks 4 days ago
Our expanded #EULAR2026 coverage is made possible by support from Bristol Myers Squibb and UCB. All content is independently chosen and produced by the RheumNow faculty.
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 5 days ago
Prof. Pedro Machado shares this important slide on a quick guide to #vaccination in patients w/ RMDs highlighting which vaccines are universally indicated, accdg to epidemiologic risk and w/ CIs.
#EULAR2026 @RheumNow https://t.co/JmTSC1uaph
sheila @RHEUMarampa ( View Tweet )
2 weeks 5 days ago
#Vaccination in Rheum
📍Hold MTX 1-2wks post vax
📍For Bcell depleters, timing is based on B-cell repop’n kinetics, not fixed calendar intervals.
THM: Assess vax need at dx, vax w/o delay
#EULAR2026 @RheumNow https://t.co/6ptl8gyBLR
Links:
sheila @RHEUMarampa ( View Tweet )
2 weeks 5 days ago
#EULAR2026 POS0438 In Part A (Phase II) RCT of Cutaneous #lupus, Litifilimab, a BDCA2 mAb improved CLASI-A vs PBO at Week 16.
-Improvement as early as Week 4
-Low viral infections. Common AE: nasopharyngitis & headache.
-Interested to see results of Part B (phase III) @RheumNow https://t.co/2zzHd9NgBi
Links:
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
2 weeks 5 days ago
#EULAR2026 Still undecided which session to attend? Please find my Conference Preview in the field of #SLE #lupus #biologics #targetedtherapy @RheumNow 😃
https://t.co/0m2p8mEgCQ https://t.co/C3xa5rPp9q
Links:
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
2 weeks 5 days ago
#EULAR2026 General Assembly is ON!
Record-breaking 5'705 abstracts from 102 countries
187 scientific sessions ahead
@rheumnow https://t.co/0kAqND11L7
Nelly ZIADE 🍀 @Nellziade ( View Tweet )
2 weeks 5 days ago
RheumNow’s expanded coverage of the #EULAR2026 Annual Meeting is sponsored by Bristol Myers Squibb and UCB. RheumNow and its faculty independently select all coverage content.
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 5 days ago
Applying updated ACR guidelines in real life isn’t always straightforward.
Two experts share insights on managing lupus nephritis beyond the textbook.
Sponsored by Aurinia https://t.co/7NAJW3LoSM https://t.co/h5RHK290pD
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 5 days ago
Advanced Practice Rheum: Safety of Biologics and Novel Agents
Dr. Jack Cush reviews safety of biologics and novel agents. This video is part of the Advanced Practice Rheum series.
https://t.co/K5TiwFA0L2 https://t.co/XoFsTMnxPC
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 5 days ago
DERM on RheumNow PODCAST (May 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, and other CTD skin disorders. Dermatology drugs, biologics, JAKs - their use, efficacy, and https://t.co/0AEAxadBFT
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 6 days ago
